Skip to main content
. 2023 Aug 4;12(1):1–9. doi: 10.1016/j.prnil.2023.07.004

Table 6.

Nomograms on prediction of life expectancy in men with clinically localized prostate cancer

Study Prediction model Outcome measure No of Patients Variables Discrimination
Albertson et al91 Probability formula OS (10 years) 451 Age, GS and index of coexistent disease category 71%
Tewari et al92 Probability graph OS (10 years) 6149 Age, race, comorbidity, PSA, GS, treatment type 63%
Cowen et al93 Probability nomogram development Life expectancy (5–15 years) 506 Age, CCI, presence of angina, systolic blood pressure, body mass index, smoking, marital status, PSA, GS, CS, treatment type 73%
Walz et al45 Probability nomogram development Life expectancy (10 years) 9131 Age, CCI, treatment type 84.3%

OS, overall survival; CCI, Charlson comorbidity index; RP, radical prostatectomy; PSA, prostate specific antigen; PSADT, prostate specific antigen doubling time; BCR, biochemical recurrence; GS, Gleason sum; CS, clinical stage; EBRT, external beam radiotherapy.